Advertisement

Bioprobes pp 43-65 | Cite as

Differentiation

  • Hiroyuki Osada

Abstract

The human body consists of about 6×1013 cells derived from a fertilized egg. A balance of proliferation and differentiation is coordinated during development. The cell should have a control mechanism that decides whether the cell should differentiate or proliferate under each environmental condition, such as nutritional state.

Keywords

Retinoic Acid Nerve Growth Factor Neurite Outgrowth Stem Cell Factor Neuro2A Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Paran M, Sachs L, Barak Y, Resnitzky P (1970) In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci USA 67:1542–1549PubMedGoogle Scholar
  2. 2.
    Fibach E, Hayashi M, Sachs L (1973) Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. Proc Natl Acad Sci USA 70:343–346PubMedGoogle Scholar
  3. 3.
    Sachs L (1987) The molecular control of blood cell development. Science 238:1374–1379PubMedGoogle Scholar
  4. 4.
    Broudy VC (1997) Stem cell factor and hematopoiesis. Blood 90:1345–1364PubMedGoogle Scholar
  5. 5.
    Krantz SB (1991) Erythropoietin. Blood 77:419–434Google Scholar
  6. 6.
    Klingmuller U (1997) The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells; Signals emanating from the erythropoietin receptor. Eur J Biochem 249:637–647PubMedGoogle Scholar
  7. 7.
    Panzenbock B, Bartunek P, Mapara MY, Zenke M (1998) Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 92:3658–3668PubMedGoogle Scholar
  8. 8.
    Pevny L, Simon MC, Robertson E, Klein WH, Tsai S-F, D’Agati V, Orkin SH, Constantini F (1991) Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257–260PubMedGoogle Scholar
  9. 9.
    Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH (1993) Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362:722–728PubMedGoogle Scholar
  10. 10.
    Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 4:2860–2867PubMedGoogle Scholar
  11. 11.
    Ferry AE, Baliga SB, Monteiro C, Pace BS (1997) Globin gene silencing in primary erythroid cultures. J Biol Chem 272:20030–20037PubMedGoogle Scholar
  12. 12.
    Broudy VC, Lin NL, Kaushansky K (1995) Thrombopoietin (c-Mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719–1726PubMedGoogle Scholar
  13. 13.
    Weich NS, Wang A, Fitzgerald M, Neben TY, Donaldson D, Giannotti J, Yez-Aldape J, Leven RM, Turner KJ (1997) Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood 90:3893–3902PubMedGoogle Scholar
  14. 14.
    Metcalf D (1995) The granulocyte-macrophage regulators: reappraisal by gene inactivation. Exp Hematol 23:569–572PubMedGoogle Scholar
  15. 15.
    Ihle JN, Kerr IM (1995) JAKs and STATs in signaling by the cytokine receptor superfamily. Trends Genet 11:69–74PubMedGoogle Scholar
  16. 16.
    Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665–676PubMedGoogle Scholar
  17. 17.
    Akagawa K, Takasuka N, Nozaki Y, Komuro I, Azuma M, Ueda M, Naito M, Takahashi K (1996) Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatasepositive osteoclast-like multinucleated giant cells from human monocytes. Blood 88:4029–4039PubMedGoogle Scholar
  18. 18.
    Friend C, Scher W, Holland JG, Sato T (1971) Hemoglobin synthesis in murine virusinduced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci USA 68:378–382PubMedGoogle Scholar
  19. 19.
    Noguchi T, Fukumoto H, Mishima Y, Obinata M (1987) Factors controlling induction of commitment of murine erythroleukemia (TSA8) cells to CFU-E (colony forming uniterythroid). Development 101:169–174PubMedGoogle Scholar
  20. 20.
    Rutherford TR, Clegg JB, Weatherall DJ (1979) K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 280:164–165PubMedGoogle Scholar
  21. 21.
    Lozzio CB, Lozzio BB, Machado EA, Fuhr JE, Lair SV, Bamberger EG (1979) Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562. Nature 281:709–710PubMedGoogle Scholar
  22. 22.
    Hoffman R, Murnane MJ, Jr BE, Prohaska R, Floyd V, Dainiak N, Forget BG, Furthmayr H (1979) Induction of erythropoietic colonies in a human chronic myelogenous leukemia cell line. Blood 54:1182–1187PubMedGoogle Scholar
  23. 23.
    Nakayama K (1998) Expression of IL-6, IL-6 receptor and its signal transducer gp130 mRNAs in megakaryocytic cell lines. Leuk Lymphoma 29:399–405PubMedGoogle Scholar
  24. 24.
    Breitman TR, Selonick SE, Collins SJ (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936–2940PubMedGoogle Scholar
  25. 25.
    Stendahl O, Dahlgren C, Hed J (1982) Physicochemical and functional changes in human leukemic cell line HL-60. J Cell Physiol 112:217–221PubMedGoogle Scholar
  26. 26.
    Tanaka H, Abe E, Miyaura C, Shiina Y, Suda T (1983) 1 α, 25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocytemacrophages, but not into granulocytes. Biochem Biophys Res Commun 117:86–92PubMedGoogle Scholar
  27. 27.
    Olsson IL, Breitman TR (1982) Induction of differentiation of the human histiocytic lymphoma cell line U937 by retinoic acid and cyclic adenosin 3′:5′-monophosphateincluding agents. Cancer Res 42:3924–3927PubMedGoogle Scholar
  28. 28.
    Gullberg U, Nilssen E, Einhorn S, Olsson I (1985) Combinations of interferon-y and retinoic acid or 1 α, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937. Exp Hematol 13:675–679PubMedGoogle Scholar
  29. 29.
    Tsuchita S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42:1530–1536Google Scholar
  30. 30.
    Yoshida M, Nomura S, Beppu T (1987) Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res 47:3688–3691PubMedGoogle Scholar
  31. 31.
    Yoshida M, Kijima M, Akita M, Beppu T (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174–17179PubMedGoogle Scholar
  32. 32.
    Omura S, Iwai Y, Takahashi Y, Sadakane N, Nakagawa A, Oiwa H, Hasegawa Y, Ikai T (1979) Herbimycin, a new antibiotic produced by a strain of Streptomyces. J Antibiot 32:255–261PubMedGoogle Scholar
  33. 33.
    Uehara Y, Murakami Y, Sugimoto Y, Mizuno S (1989) Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1. Cancer Res 49:780–785PubMedGoogle Scholar
  34. 34.
    Honma Y, Okabe-Kado J, Hozumi M, Uehara Y, Mizuno S (1989) Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity. Cancer Res 49:331–334PubMedGoogle Scholar
  35. 35.
    Kondo K, Watanabe T, Sasaki H, Uehara Y, Oishi M (1989) Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by herbimycin A, an inhibitor of protein phosphorylation. J Cell Biol 109:285–293PubMedGoogle Scholar
  36. 36.
    Tonini GP, Radzioch D, Gronberg A, Clayton M, Blasi E, Benetton G, Varesio L (1987) Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Cancer Res 47:4544–4547PubMedGoogle Scholar
  37. 37.
    Ubukata M, Tanaka C, Osada H, Isono K (1991) Respinomycin A1, a new anthracycline antibiotic. J Antibiot 44:1274–1276PubMedGoogle Scholar
  38. 38.
    Ubukata M, Osada H, Kudo T, Isono K (1993) Respinomycins, A1, A2, B, C and D, a novel group of anthracycline antibiotics. I. Taxonomy, fermentation, isolation and biological activities. J Antibiotics 46:936–941Google Scholar
  39. 39.
    Weiss S, Reynolds BA, Vescovi AL, Morshead C, Craig CG, van der Kooy D (1996) Is there a neural stem cell in the mammalian forebrain? Trends Neurosci 19:387–393PubMedGoogle Scholar
  40. 40.
    Temple S (1989) Division and differentiation of isolated CNS blast cells in microculture. Nature 340:471–473PubMedGoogle Scholar
  41. 41.
    Williams BP, Read J, Price J (1991) The generation of neurons and oligodendrocytes from a common precursor cell. Neuron 7:685–693PubMedGoogle Scholar
  42. 42.
    Milbrandt J (1986) Nerve growth factor rapidly induces c–fos mRNA in PC12 rat pheochromocytoma cells. Proc Natl Acad Sci USA 83:4789–4793PubMedGoogle Scholar
  43. 43.
    Billon N, van Grunsven LA, Rudkin BB (1996) The CDK inhibitor p21WAFl/Ciplis induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13:2047–2054PubMedGoogle Scholar
  44. 44.
    Yan GZ, Ziff EB (1997) Nerve growth factor induces transcription of the p21WAF1/Cip1 and cyclin D1 genes in PC12 cells. J Neurosci 17:6122–6132PubMedGoogle Scholar
  45. 45.
    Kalman D, Wong B, Horvai AE, Cline MJ, O’Lague PH (1990) Nerve growth factor acts through cAMP-dependent protein kinase to increase the number of sodium channels in PC12 cells. Neuron 4:355–366PubMedGoogle Scholar
  46. 46.
    Poluha W, Schonhoff CM, Harrington KS, Lachyankar MB, Crosbie NE, Bulseco DA, Ross AH (1997) A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAFl regulates neuronal differentiation of PC12 cells. J Biol Chem 272:24002–24007PubMedGoogle Scholar
  47. 47.
    Gutacker C, Klock G, Diel P, Koch-Brandt C (1999) Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells. Biochem J 339:759–766PubMedGoogle Scholar
  48. 48.
    Levi-Montalcini R, Skaper SD, Toso RD, Petrelli L, Leon A (1996) Nerve growth factor: from neutrophin to neurokine. Trends Neurosci 19:514–520PubMedGoogle Scholar
  49. 49.
    Reynolds BA, Tetzlaff W, Weiss S (1992) A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 12:4565–4574PubMedGoogle Scholar
  50. 50.
    Ehrhard PB, Ganter U, Schmutz B, Bauer J, Otten U (1993) Expression of low-affinity NGF receptor and trkB mRNA in human SH-SY5Y neuroblastoma cells. FEBS Lett 330:287–292PubMedGoogle Scholar
  51. 51.
    Ronca F, Chan SL, Yu VC (1997) 1-(5-isoquinolinesulfonyl)-2-methylpiperazine induces apoptosis in human neuroblastoma cells, SH-SY5Y, through a p53-dependent pathway. J Biol Chem 272:4252–4260PubMedGoogle Scholar
  52. 52.
    Heikkila J, Jalava A, Eriksson K (1993) The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Biochem Biophys Res Commun 197:1185–1193PubMedGoogle Scholar
  53. 53.
    Nicolini G, Miloso M, Zoia C, Di Silvestro A, Cavaletti G, Tredici G (1998) Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity. Anticancer Res 18:2477–2481PubMedGoogle Scholar
  54. 54.
    Pecio-Pinto E, Ishii DN (1984) Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Brain Res 302:323–334Google Scholar
  55. 55.
    Jalava A, Akerman K, Heikkila J (1993) Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an α-, β-, and ζ-protein kinase C-independent pathway. J Cell Physiol 155:301–312PubMedGoogle Scholar
  56. 56.
    Kakeya H, Takahashi I, Okada G, Isono K, Osada H (1995) Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, produced by a marine fungus. J Antibiot 48:733–735PubMedGoogle Scholar
  57. 57.
    Kakeya H, Onozawa C, Sato M, Arai K, Osada H (1997) Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors. J Med Chem 40:391–394PubMedGoogle Scholar
  58. 58.
    Omura S, Fujimoto T, Otoguro K, Matsuzaki K, Moriguchi R, Tanaka H, Sasaki Y (1991) Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot 44:113–116PubMedGoogle Scholar
  59. 59.
    Riboni L, Prinetti A, Bassi R, Caminiti A, Tettamanti G (1995) A mediator role of ceramide in the regulation of neuroblastoma Neuro2A cell differentiation. J Biol Chem 270:26868–26875PubMedGoogle Scholar
  60. 60.
    Yao R, Yoshihara M, Osada H (1997) Specific activation of a c-Jun NHzterminal kinase isoform and induction of neurite outgrowth in PC-12 cells by staurosporine. J Biol Chem 272:18261–18266PubMedGoogle Scholar
  61. 61.
    Yao R, Osada H (1997) Induction of neurite outgrowth in PC-12 cells by γ-lactamrelated compounds via Ras-MAP kinase signaling pathway independent mechanism. Exp Cell Res 234:223–229Google Scholar
  62. 62.
    Watanabe Y, Kakeya H, Ikoma E, Umezawa K (1993) Induction of morphological and enzymic differentiation in rat pheochromocytoma PC12h cells by stable erbstatin analogues. Drugs Exp Clin Res 19:1–6PubMedGoogle Scholar
  63. 63.
    Fenteany G, Standaert RF, Lane WS, Choi S, Corey El, Schreiber SL (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726–731PubMedGoogle Scholar
  64. 64.
    Hashimoto S, Hagino A (1989) Staurosporine-induced neurite outgrowth in PC12h cells. Exp Cell Res 184:351–359PubMedGoogle Scholar
  65. 65.
    Rasouly D, Rahamim E, Lester D, Matsuda Y, Lazarovici P (1992) Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition. Mol Pharmacol 42:35–43PubMedGoogle Scholar
  66. 66.
    Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R (1995) Toward a molecular understanding of skeletal development. Cell 80:371–378PubMedGoogle Scholar
  67. 67.
    Reddi AH (1997) Bone morphogenesis and modeling: soluble signals sculpt osteosomes in solid state. Cell 89:159–161PubMedGoogle Scholar
  68. 68.
    Mulkins M, Manolagas SC, Deftos LJ, Sussman HH (1983) 1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells. J Biol Chem 258:6219–6225PubMedGoogle Scholar
  69. 69.
    Komm BS (1988) Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81–84PubMedGoogle Scholar
  70. 70.
    Hogan BLM (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580–1594PubMedGoogle Scholar
  71. 71.
    Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T (1997) Smadl and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238:574–580PubMedGoogle Scholar
  72. 72.
    Ducy P, Karsenty G (1995) Two distinct osteoblast-specific cis acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858–1869PubMedGoogle Scholar
  73. 73.
    Ducy P, Zhang R, Geoffroy V, Ridall A, Karsenty G (1997) Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell 89:747–754PubMedGoogle Scholar
  74. 74.
    Geoffroy V, Ducy P, Karsenty G (1995) A PEBP2/AML-1-related factor increases osteocalcin promoter activity through its binding to osteoblast-cis-acting element. J Biol Chem 270:30973–30979PubMedGoogle Scholar
  75. 75.
    Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn H, Knoll JHM, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR (1997) Mutations involving the transcription factor CBFA I cause Cleidocranial Dysplasia. Cell 89:773–779PubMedGoogle Scholar
  76. 76.
    Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi KY, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of CBFA1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755–764PubMedGoogle Scholar
  77. 77.
    Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Geoffroy V, Ducy P, Karsenty G (1997) Missense mutations abolishing DNA binding OSF2/CBFA1 inpatients affected with cleidocranial dysplasia. Nature Genet 16:307–311PubMedGoogle Scholar
  78. 78.
    Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS (1995) The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/ CBF/PEBP2/RUNT domain transcription factor family: interactions with the osteocalcin gene for runt. Biochemistry 34:13125–13132PubMedGoogle Scholar
  79. 79.
    Otto F, Thornell AP, Crompton T, Denzel A, Gilmour AC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) CBFA1, a candidate gene for Cleidocranial Dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765–771PubMedGoogle Scholar
  80. 80.
    Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL (1997) Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386:81–84PubMedGoogle Scholar
  81. 81.
    Johnson RS, Spiegelman BM, Papaioannou V (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577–586PubMedGoogle Scholar
  82. 82.
    Franzoso G, Carlson L, Xing L, Poljiak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U (1997) NF-kB in osteoclast and B-cell development. Genes Dev 11:3482–3496PubMedGoogle Scholar
  83. 83.
    Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442–4111PubMedGoogle Scholar
  84. 84.
    Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lancey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Gene Dev 12:1260–1268PubMedGoogle Scholar
  85. 85.
    Taylor SM, Jones PA (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771–779PubMedGoogle Scholar
  86. 86.
    Davis RL, Weintraub H, Lassar AB (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987–1000PubMedGoogle Scholar
  87. 87.
    Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351–1359PubMedGoogle Scholar
  88. 88.
    Borycki AG, Emerson CP (1997) Muscle determination: Another key player in myogenesis? Curr Biol 7:R620–R623PubMedGoogle Scholar
  89. 89.
    Taylor MV (1998) Muscle development: A transcriptional pathway in myogenesis. Curr Biol 8:R356–R358PubMedGoogle Scholar
  90. 90.
    Thorgeirsson SS (1993) Hepatic stem cells. Am J Pathol 142:1331–1333PubMedGoogle Scholar
  91. 91.
    Shiojiri N, Lemire JM, Fausto N (1991) Cell lineages and oval cell progenitors in rat liver development. Cancer Res 51:2611–2620PubMedGoogle Scholar
  92. 92.
    Sirica AE, Mathis GA, Sano N, Elmore LW (1990) Isolation, culture, and transplantation of intrahepatic biliary epithelial cells and oval cells. Pathobiology 58:44–64PubMedGoogle Scholar
  93. 93.
    Brill S, Holst P, Sigal S, Zvibel I, Fiorino A, Ochs A, Somasundaran U, Reid LM (1993) Hepatic progenitor populations in embryonic, neonatal, and adult liver. Proc Soc Exp Biol 204:261–269PubMedGoogle Scholar
  94. 94.
    Germain L, Blouin MJ, Marceau N (1988) Biliary epithelial and hepatocytic cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, a-fetoprotein, albumin, and cell surface-exposed components. Cancer Res 48:4909–4918PubMedGoogle Scholar
  95. 95.
    Courtois G, Morgan JG, Campbell LA, Fourel G, Crabtree GR (1987) Interaction of a liver-specific nuclear factor with the fibrinogen and α 1-antitrypsin promoters. Science 238:688–692PubMedGoogle Scholar
  96. 96.
    Umek RM, Friedman AD, McKnight SL (1991) CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288–292PubMedGoogle Scholar
  97. 97.
    Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U (1990) LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev 4:1541–1551PubMedGoogle Scholar
  98. 98.
    Costa RH, Grayson DR, Darnell JEJ (1989) Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α 1-antitrypsin genes. Mol Cell Biol 9:1415–1425PubMedGoogle Scholar
  99. 99.
    Sladek FM, Zhong WM, Lai E, Darnell Jr JE (1990) Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4:2353–2365PubMedGoogle Scholar
  100. 100.
    Mietus-Snyder M, Sladek FM, Ginsburg GS, Kuo CF, Ladias JA, Darnell JEJ, Karathanasis SK (1992) Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol 12:1708–1718PubMedGoogle Scholar
  101. 101.
    Ang SL, Wierda A, Wong D, Stevens KA, Cascio S, Rossant J, Zaret KS (1993) The formation and maintenance of the definitive endoderm lineage in the mouse: involvement of HNF3/forkhead proteins. Development 119:1301–1315PubMedGoogle Scholar
  102. 102.
    Hamamoto R, Kamihira M, Iijima S (1999) Growth and differentiation of cultured fetal hepatocytes isolated various developmental stages. Biosci Biotechnol Biochem 63:395–401PubMedGoogle Scholar
  103. 103.
    Michalopoulos GK (1990) Liver regeneration: molecular mechanisms of growth control. FASEB J 4:176–187PubMedGoogle Scholar
  104. 104.
    Fujio K, Hu Z, Evarts RP, Marsden ER, Niu CH, Thorgeirsson SS (1996) Coexpression of stem cell factor and c-kit in embryonic and adult liver. Exp Cell Res 224:243–250PubMedGoogle Scholar
  105. 105.
    Knowles BB, Howe CC, Aden DP (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497–499PubMedGoogle Scholar
  106. 106.
    Nakabayashi H, Taketa K, Yamane T, Oda M, Sato J (1985) Hormonal control of a-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium. Cancer Res 45:6379–6383PubMedGoogle Scholar
  107. 107.
    Hsu SL, Lin YF, Chou CK (1992) Transcriptional regulation of transferrin and albumin genes by retinoic acid in human hepatoma cell line Hep3B. Biochem J 283:611–615PubMedGoogle Scholar
  108. 108.
    Ramos RA, Nishio Y, Maiyar AC, Simon KE, Ridder CC, Ge Y, Firestone GL (1996) Glucocorticoid-stimulated CCAAT/enhancer-binding protein alpha expression is required for steroid-induced GI cell cycle arrest of minimal-deviation rat hepatoma cells. Mol Cell Biol 16:5288–5301PubMedGoogle Scholar
  109. 109.
    Yamada K, Duong DT, Scott DK, Wang JC, Granner DK (1998) CCAAT/enhancerbinding protein beta is an accessory factor for the glucocorticoid response from the cAMP response element in the rat phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 274:5880–5887Google Scholar
  110. 110.
    Wille-Jr. J, Pittelkow MR, Shipley GD, Scott RE (1984) Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J Cell Physiol 121:31–44PubMedGoogle Scholar
  111. 111.
    Boyce ST, Ham RG (1983) Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol (Suppl) 81:335–405Google Scholar
  112. 112.
    Fuchs E (1990) Epidermal Differentiation: The bare essentials. J Cell Biol 111:2807–2814PubMedGoogle Scholar
  113. 113.
    Mdema JP, Sark-Jr. M, Backendorf C, Bos JL (1994) Calcium inhibits epidermal growth factor-induced activation of p21rasin human primary keratinocytes. Mol Cell Biol 14:7078–7085Google Scholar
  114. 114.
    Mangalam HJ, Albert VR, Ingraham HA, Kapiloff M (1989) A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 3:946–958PubMedGoogle Scholar
  115. 115.
    Kemler I, Schaffner W (1990) Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression. FASEB J 4:1444–1449PubMedGoogle Scholar
  116. 116.
    Davis RL, Cheng PF, Lassar AB, Weintraub H (1990) The MyoD DNA binding domain contains a recognition code for muscle-spicific gene activation. Cell 60:733–746PubMedGoogle Scholar
  117. 117.
    Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA (1989) Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86:802–806PubMedGoogle Scholar
  118. 118.
    Lersch R, Stellmach V, Stocks C, Giudice G, Fuchs E (1989) Isolation, sequence, and expression of a human keratin K5 gene: transcriptional regulation of keratins and insights into pairwise control. Mol Cell Biol 9:3685–3697PubMedGoogle Scholar
  119. 119.
    Marchuk D, McCrohon S, Fuchs E (1984) Remarkable conservation of structure among intermediate filament genes. Cell 39:491–498PubMedGoogle Scholar
  120. 120.
    Johnson L, Idler W, Zhou XM, Roop D, Steinert P (1985) Structure of a gene for the human epidermal 67-kDa keratin. Proc Natl Acad Sci USA 82:1896–1900PubMedGoogle Scholar
  121. 121.
    Rosenberg M, Ray Chaudhury A, Shows TB, Beau MML, Fuchs E (1988) A group of type I keratin genes on human chromosome 17: characterization and expression. Mol Cell Biol 8:722–736PubMedGoogle Scholar
  122. 122.
    Eckert RL, Green H (1986) Structure and evolution of the human involucrin gene. Cell 46:583–589PubMedGoogle Scholar
  123. 123.
    Rothnagel JA, Steinert PM (1990) The structure of the gene for mouse filaggrin and a comparison of the repeating units. J Biol Chem 265:1862–1865PubMedGoogle Scholar
  124. 124.
    Leask A, Rosenberg M, Vassar R, Fuchs E (1990) Regulation of a human epidermal keratin gene : sequence and nuclear factors involved in keratinocyte-specific transcription. Genes Dev 4:1985–1998PubMedGoogle Scholar
  125. 125.
    Leask A, Byrne C, Fychs E (1991) Transcription factor AP2 and its role in epidermalspecific gene expression. Proc Natl Acad Sci, USA 88:7948–7952PubMedGoogle Scholar
  126. 126.
    Suzuki M, Itoh T, Osada H, Rubin JS, Aaronson SA, Suzuki T, Koga N, Saito T, Mitsui Y (1993) Spleen derived growth factor, SDGF-3, is identified as keratinocyte growth factor (KGF). FEBS Lett 328:17–20PubMedGoogle Scholar
  127. 127.
    Hines MD, Allen-Hoffman BL (1996) Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes. J Biol Chem 271:6245–6251PubMedGoogle Scholar
  128. 128.
    Peehl DM, Wong ST, Rubin JS (1996) KGF and EGF differentially regulate the phenotype of prostatic epithelial cells. Growth Regul 6:22–31PubMedGoogle Scholar
  129. 129.
    Zheng C, Hoffman MP, McMillan T, Kleinman HK, O’Connell BC (1998) Growth factor regulation of the amylase promoter in a differentiating salivary acinar cell line. J Cell Physiol 177:628–635PubMedGoogle Scholar
  130. 130.
    Kuijpers AL, Van Pelt JP, Bergers M, Boegheim PJ, Den Bakker JE, Siegenthaler G, Van de Kerkhof PC, Schalkwijk J (1998) The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin. Br J Dermatol 139:380–389PubMedGoogle Scholar
  131. 131.
    Hennings H, Michael D, Cheng C (1980) Calcium regulation for growth and differentiation of mouse epidermal cells in culture. Cell 29:245–254Google Scholar
  132. 132.
    Jaken S, Yuspa H (1988) Early signals for keratinocyte differentiation: role of calcium mediated inositol lipid metabolism in normal and neoplastic epidermal cells. Carcinogenesis 9:1033–1038PubMedGoogle Scholar
  133. 133.
    Osada H, Koshino H, Isono K, Takahashi H, Kawanishi G (1991) Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor. J Antibiot 44:259–261PubMedGoogle Scholar
  134. 134.
    Takahashi H, Yamashita Y, Takaoka H, Nakamura J, Yoshihama M, Osada H (1997) Inhibitory action of reveromycin A on TGF-α-dependent growth of ovarian carcinoma BG-1 in vitro and in vivo. Oncol Res 9:7–11PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2000

Authors and Affiliations

  • Hiroyuki Osada

There are no affiliations available

Personalised recommendations